Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

Volgograd State Medical University

Nom variantlari: Stalingrad Medical Institute Volgograd Medical Academy · Волгоградский государственный медицинский университет

Davlat:
RU
ROR:
https://ror.org/04q6a0352
3
h-indeks
22
Iqtiboslar
26
Asarlar
37
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
013450510152020172018201920202021202220232024202520262017: Nashrlar 1, Iqtiboslar 02018: Nashrlar 1, Iqtiboslar 02019: Nashrlar 1, Iqtiboslar 02020: Nashrlar 3, Iqtiboslar 12021: Nashrlar 2, Iqtiboslar 12022: Nashrlar 4, Iqtiboslar 12023: Nashrlar 4, Iqtiboslar 112024: Nashrlar 3, Iqtiboslar 12025: Nashrlar 2, Iqtiboslar 32026: Nashrlar 4, Iqtiboslar 1

Iqtibos tarixi

0510152020172018201920202021202220232024202520262017: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 02020: Iqtiboslar 12021: Iqtiboslar 12022: Iqtiboslar 12023: Iqtiboslar 112024: Iqtiboslar 12025: Iqtiboslar 32026: Iqtiboslar 1

Nashr tarixi

0134520172018201920202021202220232024202520262017: Nashrlar 12018: Nashrlar 12019: Nashrlar 12020: Nashrlar 32021: Nashrlar 22022: Nashrlar 42023: Nashrlar 42024: Nashrlar 32025: Nashrlar 22026: Nashrlar 4

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520172018201920202021202220232024202520262017: h-indeks 12018: h-indeks 12019: h-indeks 12020: h-indeks 12021: h-indeks 12022: h-indeks 12023: h-indeks 22024: h-indeks 22025: h-indeks 32026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. О-AMINOACYL DERIVATIVES OF HYDROXYBENZOIC ACIDS AND EVALUATION OF THEIR BIOLOGICAL ACTIVITY20233 iqtibos
  2. Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up20213 iqtibos
  3. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)20211 iqtibos
  4. The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries20231 iqtibos
  5. 208Physicians and patients adherence to guidelines is associated with better prognosis in patients with heart failure: insights from the Optimize Heart Failure Care Program20180 iqtibos
  6. P6335The impact of patient's adherence to maintenance of euvolaemia on all-cause mortality and heart failure re-hospitalization: insights from the Optimize Heart Failure Care Program20190 iqtibos
  7. Financial Mechanisms of Digital Transformation of Agriculture20200 iqtibos
  8. SYNTHESIS OF HYDROXYBENZAMIDES WITH 6-AMINO-1,3-DIMETHYLPYRIMIDINE-2,4-DIONE20220 iqtibos
  9. Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)20220 iqtibos
  10. New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council20230 iqtibos